Virtual reality for pain reduction during intravenous injection in pediatrics: a systematic review and meta-analysis of controlled clinical trials.

Intravenous injection Meta-analysis Pain Pediatrics Systematic review Virtual reality

Journal

Clinical and experimental pediatrics
ISSN: 2713-4148
Titre abrégé: Clin Exp Pediatr
Pays: Korea (South)
ID NLM: 101761234

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 19 09 2022
accepted: 17 04 2023
medline: 16 6 2023
pubmed: 16 6 2023
entrez: 15 6 2023
Statut: ppublish

Résumé

Intravenous (IV) injections often cause pain, fear, and anxiety in pediatric patients. Virtual reality (VR) is a relatively new intervention that can be used to provide a distraction during or prepare patients for IV injections. To date, no meta-analysis has examined the evidence regarding the effectiveness of VR at reducing pain in pediatric IV injections. The PubMed, Web of Science, Scopus, and Cochrane Central Register of Controlled Trials databases were searched for articles published through August 7, 2022. The methodological quality of the studies was measured using the Delphi checklist. The chi-square test and the I2 statistic were used to assess heterogeneity across studies. A summary measure of the mean difference in pain scores between the VR and control groups was obtained using a random effects model. All statistical analyses were set at a significance level of 0.05 using Stata 14. Nine studies were included in this meta-analysis of VR interventions used during IV injections in pediatric patients. The difference in mean pain score between the intervention and control groups showed significant reductions in the VR group (mean difference, 0.47; 95% confidence interval, 0.3-0.65; I2=9.1%). No interstudy heterogeneity was observed. Our results suggest that VR effectively reduces pain associated with IV injections in pediatric patients. No interstudy heterogeneity was noted among the analyzed studies. The Delphi checklist was used to assess methodological quality.

Sections du résumé

BACKGROUND BACKGROUND
Intravenous (IV) injections often cause pain, fear, and anxiety in pediatric patients. Virtual reality (VR) is a relatively new intervention that can be used to provide a distraction during or prepare patients for IV injections.
PURPOSE OBJECTIVE
To date, no meta-analysis has examined the evidence regarding the effectiveness of VR at reducing pain in pediatric IV injections.
METHODS METHODS
The PubMed, Web of Science, Scopus, and Cochrane Central Register of Controlled Trials databases were searched for articles published through August 7, 2022. The methodological quality of the studies was measured using the Delphi checklist. The chi-square test and the I2 statistic were used to assess heterogeneity across studies. A summary measure of the mean difference in pain scores between the VR and control groups was obtained using a random effects model. All statistical analyses were set at a significance level of 0.05 using Stata 14.
RESULTS RESULTS
Nine studies were included in this meta-analysis of VR interventions used during IV injections in pediatric patients. The difference in mean pain score between the intervention and control groups showed significant reductions in the VR group (mean difference, 0.47; 95% confidence interval, 0.3-0.65; I2=9.1%). No interstudy heterogeneity was observed.
CONCLUSION CONCLUSIONS
Our results suggest that VR effectively reduces pain associated with IV injections in pediatric patients. No interstudy heterogeneity was noted among the analyzed studies. The Delphi checklist was used to assess methodological quality.

Identifiants

pubmed: 37321586
pii: cep.2022.01193
doi: 10.3345/cep.2022.01193
pmc: PMC10694551
doi:

Types de publication

Journal Article

Langues

eng

Pagination

533-537

Subventions

Organisme : Hamadan University of Medical Sciences
ID : IR.UMSHA.REC.1401.533

Références

Cyberpsychol Behav. 2006 Apr;9(2):207-12
pubmed: 16640481
Games Health J. 2019 Aug;8(4):285-293
pubmed: 31135178
Clin J Pain. 2021 Feb 1;37(2):94-101
pubmed: 33177370
Anesth Analg. 2019 Nov;129(5):1344-1353
pubmed: 31136330
JAMA Netw Open. 2021 Aug 2;4(8):e2122569
pubmed: 34432011
J Clin Nurs. 2020 Mar;29(5-6):770-777
pubmed: 31793099
J Spec Pediatr Nurs. 2018 Jan;23(1):
pubmed: 29155488
J Clin Nurs. 2020 Feb;29(3-4):503-510
pubmed: 31715039
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
PLoS One. 2021 Aug 31;16(8):e0256489
pubmed: 34464411
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
J Pediatr Nurs. 2021 May-Jun;58:e54-e62
pubmed: 33485746
Ital J Pediatr. 2019 Dec 30;45(1):171
pubmed: 31888710
Cyberpsychol Behav Soc Netw. 2014 Jun;17(6):335-45
pubmed: 24892195
J Clin Epidemiol. 1998 Dec;51(12):1235-41
pubmed: 10086815
PLoS One. 2018 Jul 27;13(7):e0200987
pubmed: 30052655
Asian Nurs Res (Korean Soc Nurs Sci). 2022 May;16(2):87-93
pubmed: 35306189
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
J Adv Nurs. 2019 Jan;75(1):30-42
pubmed: 30109720
Paediatr Anaesth. 2022 Dec;32(12):1292-1304
pubmed: 35993398

Auteurs

Ensiyeh Jenabi (E)

Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Saeid Bashirian (S)

Autism Spectrum Disorders Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Amir Mohammad Salehi (AM)

Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.

Masoud Rafiee (M)

Behavioral Disorders and Substance Abuse Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Mozhdeh Bashirian (M)

School for the Contemporary Arts, Simon Fraser University, Vancouver, Canada.

Classifications MeSH